HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.

Abstract
Pathologic axillary lymph node (ALN) status is an important prognostic factor for staging breast cancer. Currently, status is determined by histopathology following surgical excision of sentinel lymph node(s), which is an invasive, time consuming, and costly procedure with potential morbidity to the patient. Here, we describe an imaging platform for noninvasive assessment of ALN status, eliminating the need for surgical examination of patients to rule out nodal involvement. A targeted imaging probe (MamAb-680) was developed by conjugation of a mammaglobin-A-specific monoclonal antibody to a near-infrared fluorescent dye. Using DNA and tissue microarray, mammaglobin-A was validated as a cell-surface target that is expressed in ALN-positive patient samples but is not expressed in normal lymph nodes. In vivo selectivity was determined by i.v. injection of MamAb-680 into mice with mammaglobin-A-positive and -negative mammary fat pad (MFP) tumors; and by peritumoral MFP injection of the targeted imaging probe in mice with spontaneous ALN metastases. Fluorescence imaging showed that probe was only retained in positive tumors and metastases. As few as 1,000 cells that endogenously express mammaglobin-A were detected in ALN, indicating high sensitivity of this method. Translation of this approach offers considerable potential as a noninvasive clinical strategy to stage breast cancer.
AuthorsNarges K Tafreshi, Steven A Enkemann, Marilyn M Bui, Mark C Lloyd, Dominique Abrahams, Amanda S Huynh, Jongphil Kim, Stephen R Grobmyer, W Bradford Carter, Josef Vagner, Robert J Gillies, David L Morse
JournalCancer research (Cancer Res) Vol. 71 Issue 3 Pg. 1050-9 (Feb 01 2011) ISSN: 1538-7445 [Electronic] United States
PMID21169406 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Fluorescent Dyes
  • Immunoconjugates
  • Mammaglobin A
  • Neoplasm Proteins
  • RNA, Messenger
  • SCGB2A2 protein, human
  • Uteroglobin
Topics
  • Animals
  • Antibodies, Monoclonal (immunology, metabolism, pharmacokinetics)
  • Antibody Specificity
  • Breast Neoplasms (genetics, immunology, metabolism, pathology)
  • Diagnostic Imaging (methods)
  • Female
  • Fluorescent Dyes (metabolism, pharmacokinetics)
  • Humans
  • Immunoconjugates (immunology, metabolism, pharmacokinetics)
  • Lymph Nodes (immunology, metabolism, pathology)
  • Lymphatic Metastasis
  • Mammaglobin A
  • Mice
  • Mice, Nude
  • Neoplasm Proteins (biosynthesis, genetics, immunology)
  • RNA, Messenger (biosynthesis, genetics)
  • Transplantation, Heterologous
  • Uteroglobin (biosynthesis, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: